These recommendations can help you obtain better perimetry results.
What do you address first, eye pain, elevated IOP, cataracts, vein occlusion?
Continuing education and award ceremonies kept conference-goers busy.
Which comes first: peripheral iridotomy or cataract extraction?
A new generic gives glaucoma patients a cheaper option.
Two new glaucoma suspects presented with similar findings. Why wait to medicate?
Research links the disease to several neurodegenerative conditions.
A new study suggests education is the only communication factor that improves adherence.
Neuro-ophthalmic disorders can be intimidating—but you can diagnose and manage many of them. Here’s a simple guide for these serious presentations.
A new study suggests that chronic hypertension does not protect against elevated IOP.
It waxes, wanes and often spikes, creating patterns that currently go undetected. Can 24-hour monitoring devices reveal its secrets?
‘People are trapped in history and history is trapped in them,’ James Baldwin wrote.
Our job: To unlock that history as best as we can.
Today, a multitude of diagnostic technologies can support glaucomatous, corneal and posterior segment findings detected via optical coherence tomography.
We've heard about these presentations, but have yet to actually see them.
Optometrists are increasingly involved in recommending—and even performing—PIs. Here, an Oklahoma OD walks us through the procedure.
This patient returned after uncomplicated cataract surgery with an unexpected "correction" to his glaucoma. How did this happen?
Stem Cells to Reverse AMD Damage
Here, we review diagnostic strategies for a wide variety of optic nerve irregularities that may be observed in clinical practice.
Patients could measure their own IOP using a smartphone app.
Researchers have found acute angle-closure glaucoma is an inflammatory disease.
How do you respond to the glaucoma patient’s question: ‘Can you see Alzheimer’s in my eyes?’
Patients with pseudoexfoliative glaucoma often require a more thorough diagnostic work-up and earlier intervention than those with POAG. So how do these conditions differ, and why?
This uveitis patient is also a steroid responder. Which problem do you tackle first?
Is there a role for iridotomy when managing patients with pigmentary glaucoma?
As the aging population doubles and minority groups skyrocket, we face increased challenges in tailoring our glaucoma care to each patient.
Our success in managing glaucoma hinges on our ability to recognize—and make sense of—both structural and functional changes.